Alzheimer’s disease: a continuum with visual involvements

Alzheimer’s disease (AD) is the most common form of dementia affecting the central nervous system, and alteration of several visual structures has been reported. Structural retinal changes are usually accompanied by changes in visual function in this disease. The aim of this study was to analyse the differences in visual function at different stages of the pathology (family history group (FH+), mild cognitive impairment (MCI), mild AD and moderate AD) in comparison with a control group of subjects with no cognitive decline and no family history of AD.We included 53 controls, 13 subjects with FH+, 23 patients with MCI, 25 patients with mild AD and, 21 patients with moderate AD. All were ophthalmologically healthy. Visual acuity (VA), contrast sensitivity (CS), colour perception, visual integration, and fundus examination were performed.The analysis showed a statistically significant decrease in VA, CS and visual integration score between the MCI, mild AD and moderate AD groups compared to the control group. In the CS higher frequencies and in the colour perception test (total errors number), statistically significant differences were also observed in the MCI, mild AD and moderate AD groups with respect to the FH+ group and also between the control and AD groups. The FH+ group showed no statistically significant difference in visual functions compared to the control group. All the test correlated with the Mini Mental State Examination score and showed good predictive value when memory decline was present, with better values when AD was at a more advanced stage.Alterations in visual function appear in subjects with MCI and evolve when AD is established, being stable in the initial stages of the disease (mild AD and moderate AD). Therefore, visual psychophysical tests are a useful, simple and complementary tool to neuropsychological tests to facilitate diagnosis in the preclinical and early stages of AD.

[1]  Britta U. Westner,et al.  Structural and functional changes in the retina in Parkinson’s disease , 2023, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  J. Kremers,et al.  The Association Between Acquired Color Deficiency and PET Imaging of Neurodegeneration in Mild Cognitive Impairment and Alzheimer Disease , 2022, Investigative ophthalmology & visual science.

[3]  D. Han,et al.  Deficits in color detection in patients with Alzheimer disease , 2022, PloS one.

[4]  Chi-Wu Chang,et al.  Visual Function and Visual Perception among Senior Citizens with Mild Cognitive Impairment in Taiwan , 2021, Healthcare.

[5]  Natalie D. Phillips,et al.  Visual Performance and Cortical Atrophy in Vision-Related Brain Regions Differ Between Older Adults with (or at Risk for) Alzheimer's Disease. , 2021, Journal of Alzheimer's disease : JAD.

[6]  L. Ferrucci,et al.  Association of Vision Impairment With Cognitive Decline Across Multiple Domains in Older Adults , 2021, JAMA network open.

[7]  T. Wisniewski,et al.  Exploration of Rapid Automatized Naming and Standard Visual Tests in Prodromal Alzheimer Disease Detection , 2021, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[8]  A. Koyanagi,et al.  The association between objective vision impairment and mild cognitive impairment among older adults in low- and middle-income countries , 2021, Aging Clinical and Experimental Research.

[9]  J. Salazar,et al.  Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement , 2020, Frontiers in Neuroscience.

[10]  Nicole M. Armstrong,et al.  Association of Visual Impairment With Risk of Incident Dementia in a Women's Health Initiative Population. , 2020, JAMA ophthalmology.

[11]  2020 Alzheimer's disease facts and figures , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[12]  Eileen F. Tallman,et al.  Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition , 2020, Brain communications.

[13]  A. Ferreras,et al.  Ocular Involvement in Friedreich Ataxia Patients and Its Relationship with Neurological Disability, a Follow-Up Study , 2020, Diagnostics.

[14]  J. Salazar,et al.  Changes in visual function and retinal structure in the progression of Alzheimer's disease , 2019, PloS one.

[15]  H. Amièva,et al.  Vision loss and 12-year risk of dementia in older adults: the 3C cohort study , 2019, European Journal of Epidemiology.

[16]  K. Yaffe,et al.  Multiple Sensory Impairment Is Associated With Increased Risk of Dementia Among Black and White Older Adults. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[17]  M. Albert,et al.  Vision Impairment and Cognitive Outcomes in Older Adults: The Health ABC Study. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[18]  R. González-Reyes,et al.  Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview , 2018, Neural plasticity.

[19]  Jesus Pintor,et al.  Ocular Manifestations of Alzheimer's and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer's Disease , 2018, Journal of Ophthalmology.

[20]  K. Yaffe,et al.  Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment , 2018, Annals of neurology.

[21]  Keith L Black,et al.  Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. , 2017, JCI insight.

[22]  A. Sanford Mild Cognitive Impairment. , 2017, Clinics in geriatric medicine.

[23]  J. Salazar,et al.  The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma , 2017, Front. Aging Neurosci..

[24]  Mark S. Bolding,et al.  Retinal changes in the Tg-SwDI mouse model of Alzheimer’s disease , 2017, Neuroscience.

[25]  R. Klein,et al.  Age‐Related Sensory Impairments and Risk of Cognitive Impairment , 2016, Journal of the American Geriatrics Society.

[26]  Brian Barton,et al.  Changes in Visual Cortex in Healthy Aging and Dementia , 2016 .

[27]  V. Polo,et al.  Visual dysfunction and its correlation with retinal changes in patients with Alzheimer's disease , 2017, Eye.

[28]  Arthur Konnerth,et al.  Impairments of neural circuit function in Alzheimer's disease , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.

[29]  A. Pelletier,et al.  Vision Loss in Older Adults. , 2016, American family physician.

[30]  J. Cunha,et al.  Alzheimer’s disease: A review of its visual system neuropathology. Optical coherence tomography—a potential role as a study tool in vivo , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.

[31]  T. H. Ferreira-Vieira,et al.  Alzheimer's Disease: Targeting the Cholinergic System , 2016, Current neuropharmacology.

[32]  J. Salazar,et al.  Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer's Disease , 2015, Journal of ophthalmology.

[33]  J. Salazar,et al.  Macular thickness as a potential biomarker of mild Alzheimer's disease. , 2014, Ophthalmology.

[34]  Tamiko R. MaGee,et al.  Visual contrast sensitivity in Alzheimer’s disease, mild cognitive impairment, and older adults with cognitive complaints , 2013, Neurobiology of Aging.

[35]  Y. Glovinsky,et al.  Comparison between Hardy–Rand–Rittler 4th edition and Ishihara color plate tests for detection of dyschromatopsia in optic neuropathy , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.

[36]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[37]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[38]  Arne D. Ekstrom,et al.  Family history of Alzheimer's disease and hippocampal structure in healthy people. , 2010, The American journal of psychiatry.

[39]  P. Orsini,et al.  Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials , 2010, Brain Research Bulletin.

[40]  Isidro Ferrer,et al.  Diminished Perisomatic GABAergic Terminals on Cortical Neurons Adjacent to Amyloid Plaques , 2009, Front. Neuroanat..

[41]  Jen‐Hau Chen,et al.  Risk factors for dementia. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

[42]  C. Caltagirone,et al.  Color Discrimination Performance in Patients with Alzheimer’s Disease , 2009, Dementia and Geriatric Cognitive Disorders.

[43]  Grover C. Gilmore,et al.  Enhanced Stimulus Strength Improves Visual Cognition in Aging and Alzheimer's Disease , 2007, Cortex.

[44]  T. Arendt,et al.  The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease , 2006, Journal of Neural Transmission.

[45]  M. Arguin,et al.  Establishing visual category boundaries between objects: A PET study , 2005, Brain and Cognition.

[46]  Laura Fratiglioni,et al.  APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. , 2004, Archives of neurology.

[47]  T. Bekinschtein,et al.  White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[48]  A. Wirz-Justice,et al.  Colour vision deficiencies in Alzheimer's disease. , 2003, Age and ageing.

[49]  M. Bar A Cortical Mechanism for Triggering Top-Down Facilitation in Visual Object Recognition , 2003, Journal of Cognitive Neuroscience.

[50]  A. Wirz-Justice,et al.  Distribution of Melatonin MT1 Receptor Immunoreactivity in Human Retina , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[51]  Howard Chertkow,et al.  Word-Reading Thresholds in Alzheimer Disease and Mild Memory Loss: A Pilot Study , 2002, Alzheimer disease and associated disorders.

[52]  E K Warrington,et al.  A disorder of colour perception associated with abnormal colour after-images: a defect of the primary visual cortex , 2001, Journal of neurology, neurosurgery, and psychiatry.

[53]  M. Rizzo,et al.  Perception of movement and shape in Alzheimer's disease. , 1998, Brain : a journal of neurology.

[54]  Walter G. Sannita,et al.  Cholinergic modulation, visual function and Alzheimer's dementia , 1997, Vision Research.

[55]  Paul R. Martin,et al.  Evidence that Blue‐on Cells are Part of the Third Geniculocortical Pathway in Primates , 1997, The European journal of neuroscience.

[56]  Sandra E. Black,et al.  Focal Cortical Atrophy Syndromes , 1996, Brain and Cognition.

[57]  M. Dick,et al.  Vision in dementia: contrast effects. , 1996, Neurological research.

[58]  S. Corkin,et al.  Visual dysfunction predicts cognitive deficits in Alzheimer's disease. , 1995, Optometry and vision science : official publication of the American Academy of Optometry.

[59]  P J Whitehouse,et al.  Contrast sensitivity in Alzheimer's disease: a 1-year longitudinal analysis. , 1995, Optometry and vision science : official publication of the American Academy of Optometry.

[60]  J. Elias,et al.  Contrast sensitivity dysfunction in Alzheimer's disease , 1993, Neurology.

[61]  D. Levine,et al.  The visual variant of Alzheimer's disease , 1993, Neurology.

[62]  R. Mayeux,et al.  Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders. , 1991, Archives of neurology.

[63]  Alfredo A. Sadun,et al.  Retinal ganglion cell degeneration in Alzheimer's disease , 1989, Brain Research.

[64]  D B Elliott,et al.  CONTRAST SENSITIVITY DECLINE WITH AGEING: A NEURAL OR OPTICAL PHENOMENON? * , 1987, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[65]  M. Borchert,et al.  Assessment of visual impairment in patients with Alzheimer's disease. , 1987, American journal of ophthalmology.

[66]  M J Campbell,et al.  Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[67]  A. Bron,et al.  Effect of age on contrast sensitivity function: uniocular and binocular findings. , 1985, The British journal of ophthalmology.

[68]  M. Moscovitch,et al.  Visual processing deficits as assessed by spatial frequency contrast sensitivity and backward masking in normal ageing and Alzheimer's disease. , 1984, Brain : a journal of neurology.

[69]  L. Walker Aβ Plaques. , 2020, Free neuropathology.

[70]  V. Jindal Interconnection Between Brain and Retinal Neurodegenerations , 2014, Molecular Neurobiology.

[71]  R. Liutkeviciene,et al.  Associations between contrast sensitivity and aging. , 2013, Medicina.

[72]  J. Molinuevo,et al.  [Perception Digital Test (PDT) for the assessment of incipient visual disorder in initial Alzheimer's disease]. , 2007, Neurologia.

[73]  A. Cronin-Golomb,et al.  The impact of acuity on performance of four clinical measures of contrast sensitivity in Alzheimer's disease. , 2003, The journals of gerontology. Series B, Psychological sciences and social sciences.

[74]  M. Mendez,et al.  Optometric management of patients with Alzheimer's disease. , 1997, Journal of the American Optometric Association.